Table 1 Characteristics of the study population
From: Benefits of resistance exercise in lean women with fibromyalgia: involvement of IGF-1 and leptin
Characteristics | All patients n = 43 | Lean n = 18 | Overweight n = 17 | Obese n = 8 | p Valuea Lean vs overweight | p Valuea Lean vs obese | p Valuea Overweight vs obese |
|---|---|---|---|---|---|---|---|
Age (years) | 51 (25 to 64) | 50 (25 to 63) | 53 (34 to 64) | 51 (25 to 63) | 0.351 | 0.807 | 0.711 |
BMI (kg/m2) | 25.6 (20.9 to 39.9) | 23.1 (20.9 to 24.96) | 26.2 (25.1 to 29.9) | 35.2 (30.8 to 39.9) | <0.001 | <0.001 | <0.001 |
Symptom duration (years) | 9 (0 to 35) | 8 (1 to 20) | 10 (0 to 35) | 7 (1 to 26) | 0.386 | 0.892 | 0.628 |
Tender points (n) | 16 (11 to 18) | 16 (12 to 18) | 16 (11 to 18) | 17 (15 to 18) | 0.909 | 0.311 | 0.238 |
Pharmacologic treatment, N (%) | Â | Â | Â | Â | p Valueb Lean vs overweight | p Valueb Lean vs obese | p Valueb Overweight vs obese |
NSAID/paracetamol | 34 (79) | 12 (67) | 15 (88) | 7 (88) | 0.264 | 0.531 | 0.958 |
Opioids for mild to moderate pain. Yes | 6 (14) | 2 (11) | 3 (18) | 1 (12) | 0.945 | 0.918 | 0.743 |
Antidepressants. Yes | 22 (51) | 8 (44) | 11 (65) | 3 (38) | 0.3880 | 0.741 | 0.397 |
Anticonvulsives. Yes | 4 (9) | 2 (11) | 2 (6) | 1 (12) | 0.9516 | 0.918 | 0.958 |
Sedatives. Yes | 7 (16) | 3(17) | 4 (24) | 0 (0) | 0.9326 | 0.574 | 0.362 |